Cost Utility of Bronchial Thermoplasty for Severe Asthma: Implications for Future Cost-Effectiveness Analyses Based on Phenotypic Heterogeneity

References

• Wechsler ME, Laviolette M, Rubin AS, et al. Bronchial thermoplasty: long-term safety and effectiveness in patients with severe persistent asthma. J Allergy Clin Immunol. 2013;132(6):1295–1302. doi:10.1016/j.jaci.2013.08.009
   PubMed Web of Science ®Google Scholar
• Hekking -P-PW, Wener RR, Amelink M, Zwinderman AH, Bouvy ML, Bel EH. The prevalence of severe refractory asthma. J Allergy Clin Immunol. 2015;135(4):896–902. doi:10.1016/j.jaci.2014.08.042
   PubMed Web of Science ®Google Scholar
• Hanratty CE, Matthews JG, Arron JR, et al. A randomised pragmatic trial of corticosteroid optimization in severe asthma using a composite biomarker algorithm to adjust corticosteroid dose versus standard care: study protocol for a randomised trial. Trials. 2018;19(1):5. doi:10.1186/s13063-017-2384-7
   PubMed Web of Science ®Google Scholar
• Mansur AH, Srivastava S, Mitchell V, Sullivan J, Kasujee I. Long term clinical outcomes of omalizumab therapy in severe allergic asthma: study of efficacy and safety. Respir Med. 2017;124:36–43. doi:10.1016/j.rmed.2017.01.008
   PubMed Web of Science ®Google Scholar
• Stróżek J, Samoliński BK, Kłak A, et al. The indirect costs of allergic diseases. Int J Occup Med Environ Health. 2019;32(3):281–290. doi:10.13075/ijomeh.1896.01275
   PubMed Web of Science ®Google Scholar
• Settipane RA, Kreindler JL, Chung Y, Tkacz J. Evaluating direct costs and productivity losses of patients with asthma receiving GINA 4/5 therapy in the United States. Ann Allergy Asthma Immunol. 2019;123(6):564–572.e3. doi:10.1016/j.anai.2019.08.462
   PubMed Web of Science ®Google Scholar
• Denlinger LC, Heymann P, Lutter R, Gern JE. Exacerbation-prone asthma. J Allergy Clin Immunol Pract. 2020;8(2):474–482. doi:10.1016/j.jaip.2019.11.009
   PubMed Web of Science ®Google Scholar
• Lucas C, Aly S, Touboul C, Sellami R, Guillaume X, Garcia G. Patient-reported outcome in two chronic diseases: a comparison of quality of life and response profiles in severe migraine and severe asthma. Patient Relat Outcome Meas. 2020;11:27–37. doi:10.2147/PROM.S222597
   PubMed Web of Science ®Google Scholar
• Wang AL, Tantisira KG. Personalized management of asthma exacerbations: lessons from genetic studies. Expert Rev Precis Med Drug Dev. 2016;1(6):487–495. doi:10.1080/23808993.2016.1269600
   PubMed Web of Science ®Google Scholar
• Delgado J, Dávila IJ, Domínguez-Ortega J; Group of Severe Asthma (SEAIC). Clinical recommendations for the management of biological treatments in severe asthma patients: a consensus statement. J Investig Allergol Clin Immunol. 2020. doi:10.18176/jiaci.0638
   Web of Science ®Google Scholar
• Domingo C, Pomares X, Morón A, Sogo A. Dual monoclonal antibody therapy for a severe asthma patient. Front Pharmacol. 2020;11:587621. doi:10.3389/fphar.2020.587621
   PubMed Web of Science ®Google Scholar
• Bermejo I, Stevenson M, Cooper K, et al. Mepolizumab for treating severe eosinophilic asthma: an evidence review group perspective of a NICE single technology appraisal. Pharmacoeconomics. 2018;36(2):131–144. doi:10.1007/s40273-017-0571-8
   PubMed Web of Science ®Google Scholar
• Canadian Agency for Drugs and Technology in Health. Bronchial Thermoplasty for Severe Asthma: A Review of the Clinical and Cost-Effectiveness, and Guidelines. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2015.
   Google Scholar
• Langton D, Lee P. Bronchial thermoplasty: redefining its role. Respirology. 2020;25(9):981–986. doi:10.1111/resp.13887
   PubMed Web of Science ®Google Scholar
• Langton D, Ing A, Fielding D, et al. Safety and effectiveness of bronchial thermoplasty when FEV1 is less than 50. Chest. 2020;157(3):509–515. doi:10.1016/j.chest.2019.08.2193
   PubMed Web of Science ®Google Scholar
• Castro M, Rubin AS, Laviolette M, et al. Effectiveness and safety of bronchial thermoplasty in the treatment of severe asthma: a multicenter, randomized, double-blind, sham-controlled clinical trial. Am J Respir Crit Care Med. 2010;181(2):116–124. doi:10.1164/rccm.200903-0354OC
   PubMed Web of Science ®Google Scholar
• Pavord ID, Cox G, Thomson NC, et al. Safety and efficacy of bronchial thermoplasty in symptomatic, severe asthma. Am J Respir Crit Care Med. 2007;176(12):1185–1191. doi:10.1164/rccm.200704-571OC
   PubMed Web of Science ®Google Scholar
• Pavord ID, Thomson NC, Niven RM, et al. Safety of bronchial thermoplasty in patients with severe refractory asthma. Ann Allergy Asthma Immunol. 2013;111(5):402–407. doi:10.1016/j.anai.2013.05.002
   PubMed Web of Science ®Google Scholar
• Torrego A, Solà I, Munoz AM, et al. Bronchial thermoplasty for moderate or severe persistent asthma in adults. Cochrane Database Syst Rev. 2014;(3):CD009910. doi:10.1002/14651858.CD009910.pub2
   PubMed Web of Science ®Google Scholar
• Zafari Z, Sadatsafavi M, Marra CA, Chen W, FitzGerald JM. Cost-effectiveness of bronchial thermoplasty, omalizumab, and standard therapy for moderate-to-severe allergic asthma. PLoS One. 2016;11(1):e0146003. doi:10.1371/journal.pone.0146003
   PubMed Web of Science ®Google Scholar
• Langton D, Sha J, Guo S, et al. Bronchial thermoplasty versus mepolizumab: comparison of outcomes in a severe asthma clinic. Respirology. 2020;25(12):1243–1249. doi:10.1111/resp.13830
   PubMed Web of Science ®Google Scholar
• O’Reilly A, Lane S. What is the role of bronchial thermoplasty in the management of severe asthma? Ther Adv Respir Dis. 2018;12:1753466618792410. doi:10.1177/1753466618792410
   Web of Science ®Google Scholar
• Zein JG, Menegay MC, Singer ME, et al. Cost effectiveness of bronchial thermoplasty in patients with severe uncontrolled asthma. J Asthma. 2016;53(2):194–200. doi:10.3109/02770903.2015.1072552
   PubMed Web of Science ®Google Scholar
• Nguyen HV, Bose S, Mital S, et al. Is bronchial thermoplasty cost-effective as treatment for problematic asthma patients? Singapore’s perspective on a global model. Respirology. 2017;22(6):1102–1109. doi:10.1111/resp.13027
   PubMed Web of Science ®Google Scholar
• Cangelosi MJ, Ortendahl JD, Meckley LM, et al. Cost-effectiveness of bronchial thermoplasty in commercially-insured patients with poorly controlled, severe, persistent asthma. Expert Rev Pharmacoecon Outcomes Res. 2015;15(2):357–364. doi:10.1586/14737167.2015.978292
   PubMed Web of Science ®Google Scholar
• Husereau D, Drummond M, Petrou S. Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement. Int J Technol Assess Health Care. 2013;29:117–122.
   PubMed Web of Science ®Google Scholar
• Siebert U, Alagoz O, Bayoumi AM, et al. State-transition modeling: a report of the ISPOR-SMDM modeling good research practices task force–3. Value Health. 2012;15(6):812–820. doi:10.1016/j.jval.2012.06.014
   PubMed Web of Science ®Google Scholar
• Olariu E, Cadwell KK, Hancock E, Trueman D, Chevrou-Severac H. Current recommendations on the estimation of transition probabilities in Markov cohort models for use in health care decision-making: a targeted literature review. Clinicoecon Outcomes Res. 2017;9:537–546. doi:10.2147/CEOR.S135445
   PubMed Web of Science ®Google Scholar
• Bousquet J, Cabrera P, Berkman N, et al. The effect of treatment with omalizumab, an anti-IgE antibody, on asthma exacerbations and emergency medical visits in patients with severe persistent asthma. Allergy. 2005;60(3):302–308. doi:10.1111/j.1398-9995.2004.00770.x
   PubMed Web of Science ®Google Scholar
• Global Initiative for Asthma - GINA. Available from: https://ginasthma.org/. Accessed November 7, 2020.
   Google Scholar
• Reich O, Signorell A, Busato A. Place of death and health care utilization for people in the last 6 months of life in Switzerland: a retrospective analysis using administrative data. BMC Health Serv Res. 2013;13:116. doi:10.1186/1472-6963-13-116
   PubMed Web of Science ®Google Scholar
• Feudtner C, DiGiuseppe DL, Neff JM. Hospital care for children and young adults in the last year of life: a population-based study. BMC Med. 2003;1:3. doi:10.1186/1741-7015-1-3
   PubMed Web of Science ®Google Scholar
• Keim-Malpass J, Erickson JM, Malpass HC. End-of-life care characteristics for young adults with cancer who die in the hospital. J Palliat Med. 2014;17(12):1359–1364. doi:10.1089/jpm.2013.0661
   PubMed Web of Science ®Google Scholar
• Sanders GD, Neumann PJ, Basu A, et al. Recommendations for conduct, methodological practices, and reporting of cost-effectiveness analyses: second panel on cost-effectiveness in health and medicine. JAMA. 2016;316(10):1093–1103. doi:10.1001/jama.2016.12195
   PubMed Web of Science ®Google Scholar
• Chaudhuri R, Rubin A, Sumino K, et al. Safety and effectiveness of bronchial thermoplasty after 10 years in patients with persistent asthma (BT10+): a follow-up of three randomised controlled trials. Lancet Respir Med. 2021;9(5):457–466. doi:10.1016/S2213-2600(20)30408-2
   PubMed Web of Science ®Google Scholar
• Jakubiak-Lasocka J, Jakubczyk M. Cost-effectiveness versus cost-utility analyses: what are the motives behind using each and how do their results differ?-A polish example. Value in Health Regional Issues. 2014;4:66–74. doi:10.1016/j.vhri.2014.06.008
   PubMedGoogle Scholar
• Lavelle TA, Kent DM, Lundquist CM, et al. Patient variability seldom assessed in cost-effectiveness studies. Med Decis Making. 2018;38(4):487–494. doi:10.1177/0272989X17746989
   PubMed Web of Science ®Google Scholar
• Arora P, Boyne D, Slater JJ, Gupta A, Brenner DR, Druzdzel MJ. Bayesian networks for risk prediction using real-world data: a tool for precision medicine. Value Health. 2019;22(4):439–445. doi:10.1016/j.jval.2019.01.006
   PubMed Web of Science ®Google Scholar
• Salvi E, Parimbelli E, Quaglini S, Sacchi L. Eliciting and exploiting utility coefficients in an integrated environment for shared decision-making. Methods Inf Med. 2019;58(1):24–30. doi:10.1055/s-0039-1692416
   PubMed Web of Science ®Google Scholar
• Chongmelaxme B, Chaiyakunapruk N, Dilokthornsakul P. Incorporating adherence in cost-effectiveness analyses of asthma: a systematic review. J Med Econ. 2019;22(6):554–566. doi:10.1080/13696998.2019.1572014
   PubMed Web of Science ®Google Scholar
• Krishnan V, Diette GB, Rand CS, et al. Mortality in patients hospitalized for asthma exacerbations in the United States. Am J Respir Crit Care Med. 2006;174(6):633–638. doi:10.1164/rccm.200601-007OC
   PubMed Web of Science ®Google Scholar
• CDC WONDER. Available from: https://wonder.cdc.gov/. Accessed November 7, 2020.
   Google Scholar